Allena Pharmaceuticals Achieves Alignment with FDA on Phase 3 Program and Accelerated Approval Pathway for Reloxaliase in Enteric Hyperoxaluria

Editas Medicine to Present at the 37th Annual J.P. Morgan Healthcare Conference

GBT to Present at the 37th Annual J.P. Morgan Healthcare Conference

Jounce Therapeutics to Present at the 37th Annual J.P. Morgan Healthcare Conference

Kala Pharmaceuticals to Present at 37th Annual J.P. Morgan Healthcare Conference